
 

#Ù¾Ø±ÙˆÚ˜Ù‡_Ø§Ø±Ø´Ø¯


- [ ] Ø¨Ø§ Ú†Ù‡ Ø±ÙˆØ´ÛŒ Ù…Ù‚Ø§Ù„Ø§ØªÛŒ Ú©Ù‡ Ø§Ø­ØªÙ…Ø§Ù„Ø§ Ø¯ÛŒØªØ§ÛŒ Ù…Ù†Ø§Ø³Ø¨ Ø¯Ø§Ø±Ù† Ø±Ùˆ Ù¾ÛŒØ¯Ø§ Ú©Ù†Ù…
- [ ] Ú†Ø¬ÙˆØ±ÛŒ ÙÛŒÙ„ØªØ±Ø´ÙˆÙ† Ú©Ù†Ù…

Ø¯Ø±ØµÙˆØ±Øª Ø²ÛŒØ§Ø¯ Ø¨ÙˆØ¯Ù† Ù…Ù‚Ø§Ù„Ø§Øª Ø¨Ø§ÛŒØ¯ Ø§Ø² Ø±ÙˆØ´ Ù‡Ø§ÛŒ [[automatic data extraction]] Ø§Ø³ØªÙØ§Ø¯Ù‡ Ú©Ù†Ù…




---


# Ø§Ø³ØªÙØ§Ø¯Ù‡ Ø§Ø² Ø§Ø³Ú©ÙˆÙ¾ÙˆØ³ Ø¨Ø±Ø§ÛŒ Ø³Ø±Ú† Ù…Ù‚Ø§Ù„Ø§Øª

## Ø³Ø±Ú† Ú©Ù„ÛŒ:

```
TITLE-ABS-KEY(
  (doxorubicin OR dox OR "anthracycline*" OR "adriamycin") AND 
  ("drug loading" OR "loading capacity" OR "drug delivery" OR "drug release" OR "drug encapsulation" OR "controlled release" OR "payload" OR "cargo" OR "adsorption" OR "absorption") AND 
  ("metal-organic framework*" OR mof OR mofs OR "porous material*" OR "nanomaterial*" OR "nanocarrier*") AND 
  (zif OR mil OR copper OR cu OR "zeolitic imidazolate framework*" OR "materials of institut lavoisier" OR "copper-based") AND
  ("porosity" OR "surface area" OR "pore size" OR "BET" OR "langmuir" OR "PXRD" OR "TGA" OR "SEM" OR "TEM" OR "release kinetics" OR "sustained release" OR "burst release" OR "pH-responsive" OR "stimuli-responsive" OR "cancer therapy" OR "targeted delivery")
) AND 
(EXCLUDE(DOCTYPE, "re"))
```

---
## Ù‡Ù…Ù‡ Ø¯Ø§Ø±Ùˆ Ù‡Ø§ - Ù…Ø§Ù Ùˆ Ù†ÙˆØ¹ Ù…Ø§Ù Ø¬Ø¯Ø§

```
TITLE-ABS-KEY ( ( doxorubicin OR dox OR "anthracycline*" OR "adriamycin" OR "carboplatin" ) AND ( "metal-organic framework*" OR mof OR mofs ) AND ( zif OR mil OR copper OR cu OR "zeolitic imidazolate framework*" OR "materials of institut lavoisier" OR "copper-based" OR "copper" OR "cupper-based" OR "cupper" ) ) AND ( EXCLUDE ( DOCTYPE , "re" ) )
```

275 Ù…Ù‚Ø§Ù„Ù‡
![[Pasted image 20240721114634.png]]

---
## Ù‡Ù…Ù‡ Ø¯Ø§Ø±Ùˆ Ù‡Ø§ - Ù…Ø§Ù Ùˆ Ù†ÙˆØ¹ Ù…Ø§Ù Ø¨Ø§Ù‡Ù…

^9bdea8

```
TITLE-ABS-KEY ( ( doxorubicin OR dox OR "anthracycline*" OR "adriamycin" OR "carboplatin" ) AND ( "metal-organic framework*" OR mof OR mofs OR zif OR "MIL" OR "zeolitic imidazolate framework*" OR "materials of institut lavoisier" ) ) AND ( EXCLUDE ( DOCTYPE , "re" ) )
```

685 Ù…Ù‚Ø§Ù„Ù‡
![[Pasted image 20240721115119.png]]

---
## ÙÙ‚Ø· dox - Ù…Ø§Ù Ùˆ Ù†ÙˆØ¹ Ù…Ø§Ù Ø¨Ø§Ù‡Ù…

```
TITLE-ABS-KEY ( ( doxorubicin OR dox ) AND ( "metal-organic framework*" OR mof OR mofs OR zif OR "MIL" OR "zeolitic imidazolate framework*" OR "materials of institut lavoisier" ) ) AND ( EXCLUDE ( DOCTYPE , "re" ) )
```
662 Ù…Ù‚Ø§Ù„Ù‡
![[Pasted image 20240721120544.png]]


# Ù„ÛŒØ³Øª Ù…Ù‚Ø§Ù„Ø§Øª
Ù…Ø±Ø¨ÙˆØ· Ø¨Ù‡ Ø³Ø±Ú† [[Ù¾ÛŒØ¯Ø§ Ú©Ø±Ø¯Ù† Ù…Ù‚Ø§Ù„Ø§Øª Ù…Ù†Ø§Ø³Ø¨ Ø¨Ø±Ø§ÛŒ Ø¬Ù…Ø¹ Ø¢ÙˆØ±ÛŒ Ø¯Ø§Ø¯Ù‡#^9bdea8| Ù‡Ù…Ù‡ Ù†ÙˆØ¹ Ø¯Ø§Ø±ÙˆØŒ Ù…Ø§Ù Ùˆ Ù†ÙˆØ¹ Ù…Ø§Ù Ø¨Ø§Ù‡Ù…]]
ğŸ—ƒï¸[[mof papers.xlsx|Ø§Ú©Ø³Ù„ Ù„ÛŒØ³Øª Ù…Ù‚Ø§Ù„Ø§Øª]]



# Ù†Ú©Ø§Øª
![[Pasted image 20240719191718.png]]
The efficiency of DOX loading in the final step is directly related to preparation parameters such as Polymer/DOX ratio and TPP concentration, and even to the stirring rate during the procedure
[[Co-delivery of carboplatin and doxorubicin using ZIF-8 coated chitosan-poly(N-isopropyl acrylamide) nanoparticles through a dual pH thermo responsive strategy to breast cancer cells|ref]]


# Ù…Ù‚Ø§Ù„Ø§Øª

Ø±Ù†Ú¯ Ù‡Ø§ÛŒÙ„Ø§ÛŒØª Ù‡Ø§ÛŒ ØªÙˆ PDF (Ø¨Ø¬Ø² Ù…Ù‚Ø§Ù„Ù‡ Ø§ÙˆÙ„):
Ø§<span style="color:#ff7070">Ù‚Ø±Ù…Ø²:</span> Ø§Ø¨Ù‡Ø§Ù… Ø¯Ø± Ø§Ø³ØªÙØ§Ø¯Ù‡ / Ø³ÙˆØ§Ù„
Ø§<span style="color:#0070c0">Ø¢Ø¨ÛŒ</span>: Ø¯Ø§Ø¯Ù‡ ÛŒ Ø¨Ø±Ø¯Ø§Ø´ØªÙ‡ Ø´Ø¯Ù‡


- [x] [[Co-delivery of carboplatin and doxorubicin using ZIF-8 coated chitosan-poly(N-isopropyl acrylamide) nanoparticles through a dual pH thermo responsive strategy to breast cancer cells]]

- [x] [[Fe 3 O 4 -Incorporated Metal-Organic Framework for Chemo Ferroptosis Synergistic Anti-Tumor via the Enhanced Chemodynamic Therapy]]

- [x] [[Metal organic framework coated vesicular nanoaggregates an intelligent â€˜vehicleâ€™ for sustained and leakage proof release of doxorubicin]]
- [ ] 

# Ø³ÙˆØ§Ù„Ø§Øª
- [ ] Ú©Ø±ÙˆÛŒ ÙØ±Ø¶ Ú©Ø±Ø¯Ù† Ø­ÙØ±Ø§Øª Ø¨Ø±Ø§ÛŒ Ù…Ø­Ø§Ø³Ø¨Ù‡ Ø­Ø¬Ù… Ø§Ø² Ø´Ø¹Ø§Ø¹ Ù‡ÛŒØ¯Ø±ÙˆØ¯ÛŒÙ†Ø§Ù…ÛŒÚ©
- [ ] Ø¯Ø± Ù†Ø¸Ø± Ú¯Ø±ÙØªÙ† Ø§Ù†Ø¯Ø§Ø²Ù‡ Ú©Ù„ Ù†Ø§Ù†ÙˆÙ¾Ø§Ø±ØªÛŒÚ©Ù„ Ø¨Ø¹Ø¯ Ø§Ø² Ù„ÙˆØ¯ 
- [ ] Ø§Ù‡Ù…ÛŒØª Ø¯Ø§Ø´ØªÙ† Ù„ÙˆØ¯ÛŒÙ†Ú¯ Ù‡Ù… Ø²Ù…Ø§Ù† Ø¨ÛŒØ´ØªØ± Ø§Ø² ÛŒÚ© Ø¯Ø§Ø±Ùˆ Ø¨Ø±Ø§ÛŒ Ø°Ú©Ø± Ú©Ø±Ø¯Ù†
- [ ] Ø¯Ø±Ø®ÙˆØ§Ø³Øª Ø¯Ø§Ø¯Ù‡ Ø§Ø² Ú©Ø³Ø§ÛŒÛŒ Ú©Ù‡ Ù…Ù‚Ø§Ù„Ø§ØªÙˆ Ù…Ù†ØªØ´Ø± Ú©Ø±Ø¯Ù†ØŸ
- [ ] Ù¾Ø§Ø±Ø§Ù…ØªØ± Ù‡Ø§ÛŒ Ù…Ù‡Ù… ÙØ±Ø§ÛŒÙ†Ø¯ ÛŒ Ù„ÙˆØ¯ÛŒÙ†Ú¯ (Ù…Ø¯Øª Ùˆ Ø¯ÙˆØ± Ø§Ø³ØªÛŒØ±Ø±ØŒ Ù…Ø´Ø®ØµØ§Øª Ù…Ø­Ù„ÙˆÙ„ Ø¯Ø§Ø±ÙˆØŒ Ø§Ù‡Ù…ÛŒØª ØªØ±Ú©ÛŒØ¨ Ù…Ø­Ù„ÙˆÙ„ Ø¯Ø§Ø±Ùˆ {Ù…Ø«Ù„Ø§ Ø§ÛŒÙ†Ú©Ù‡ Ù‡Ù…Ø²Ù…Ø§Ù† Ù‡Ù… Ù¾ÙˆØ´Ø´ Ø¯Ø§Ø¯Ù‡ Ø´Ø¯Ù‡ Ù‡Ù… Ù„ÙˆØ¯ Ø´Ø¯Ù‡}) 
- [ ] Ù¾ØªØ§Ù†Ø³ÛŒÙ„ Ø²ØªØ§ Ú©Ø¯ÙˆÙ… Ø¨Ø®Ø´Ø§ Ø§Ù‡Ù…ÛŒØª Ø¯Ø§Ø±Ù‡ØŸ
- [ ] Ù…Ù‚Ø¯Ø§Ø± EE Ø¨Ø±Ø§ÛŒ Ù†Ù…ÙˆÙ†Ù‡ cbp 
- [ ] Ù…Ù‚Ø§Ø¯ÛŒØ± Ú¯Ø²Ø§Ø±Ø´ Ù†Ø´Ø¯Ù‡ Ø¨Ø±Ø§ÛŒ MOF Ù‡Ø§ Ù…Ø«Ù„ surface area Ø¨Ø§ Ù…Ù‚Ø¯Ø§Ø± Ù…Ø´Ø®Øµ ØŸ









#Goal